Evidence map›Paper›PMID 24559197›Full record

ArticleItalian journal of pediatrics2014

Epidemiology of Toxoplasma and CMV serology and of GBS colonization in pregnancy and neonatal outcome in a Sicilian population.

Giuseppe Puccio, Cinzia Cajozzo, Laura Antonella Canduscio, Lucia Cino, Amelia Romano, Maria Gabriella Schimmenti, Mario Giuffrè, Giovanni Corsello

Open access · goldAbstract read
In one paragraph

Article in Italian journal of pediatrics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Systematic review and modelling ofEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Pooled it
  2. Pooled it
  3. Frequency of CMV testing during pregnancy-a retrospective study.Archives of gynecology and obstetrics · 2025
    Article
  4. Article
  5. Article
  6. Anti-Pathogens (Basel, Switzerland) · 2023
    Review
  7. Review
  8. Microorganisms · 2023
    Article
  9. Article
  10. Article
  11. Pathogens (Basel, Switzerland) · 2020
    Article
  12. Article
  13. Group BMicrobiology spectrum · 2019
    Review
  14. Article
  15. Detection of TORCH pathogens in children with congenital cataracts.Experimental and therapeutic medicine · 2016
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Giuseppe PuccioDepartment of Sciences for Health Promotion and Mother and Child Care, University of Palermo, Palermo, Italy. gipuccio@gmail.com.
Cinzia Cajozzo
Laura Antonella Canduscio
Lucia Cino
Amelia Romano
Maria Gabriella Schimmenti
Mario Giuffrè
Giovanni Corsello
University of Palermo · ITAnsaldo (Italy) · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAim of our study is to analyze the immunological status in pregnancy for two main TORCH agents, Toxoplasma and Cytomegalovirus (CMV), and the results of group B streptococcus (GBS) screening, assessing the risk for congenital infection in a population from Palermo, Italy.

methodsWe retrospectively analyzed the medical records of all inborn live newborns who were born in our division during 2012, gathering information about the mother, the pregnancy and neonatal hospitalization at birth. Whenever data were available, we categorized the serologic status of the mothers for Toxoplasma and CMV. We also considered the results of rectal and vaginal swabs for GBS. We compared the results in Italian and immigrant mothers. The neonatal outcome was evaluated in all cases at risk.

resultsPrevalence of anti-Toxo IgG antibodies was 17.97%, and was significantly higher in immigrant women (30% vs 16.4% in Italian women; p = 0.0008). Prevalence of anti-CMV IgG antibodies was 65.87%. Again, it was significantly higher in immigrant women (91.4% vs 62.5%, p = 3.31e-08). We compared those data with a previous study performed in our hospital in 2005-2006, and found that the prevalence of anti-Toxoplasma and anti-CMV antibodies in our population has remained stable, both in the immigrant and in the local population. Seroconversion rates and neonatal infections were rare: no seroconversions were observed for Toxoplasma, 4 seroconversions for CMV. One neonatal Toxoplasma infection and two neonatal CMV infections were documented. In some cases with dubious patterns or probable persistence of IgM, we performed additional tests and follow-up. Vaginal and rectal swabs were positive for GBS in 7.98% of cases, with no significant difference between the Italian and the immigrant population. No GBS neonatal sepsis was documented.

conclusionsThe prevalence of Toxoplasma IgG antibodies in pregnant women was low in our population, if compared with European countries and with other parts of Italy, and is significantly higher in immigrant women. The prevalence of CMV IgG antibodies was intermediate if compared to other countries, and it was higher in immigrant women. GBS positivity was low, and comparable in Italian and immigrant mothers. Neonatal infection was rare for all these agents.

Indexed as

AdolescentAdultAnimalsAntibodies, Anti-IdiotypicAntibodies, BacterialAntibodies, ProtozoanAntibodies, ViralCytomegalovirusCytomegalovirus InfectionsFemaleHumansImmunoglobulin GInfant, NewbornInfant, Newborn, DiseasesMaleMiddle AgedAntibodies, Anti-IdiotypicAntibodies, BacterialAntibodies, ProtozoanAntibodies, ViralImmunoglobulin G

Identifiers

PMID24559197
PMCPMC3936856
OpenAlexW2146856572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.